Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01863901 · ClinicalTrials.gov registry record · NA
Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device
A NA study, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01863901: Completed NA study, sponsored by Pacira Pharmaceuticals.
NCT01863901 is a NA study that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01863901, a NA study, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
A proof of concept study to evaluate the feasibility of safe and effective treatment of upper limb spasticity using the Cryo-Touch III Device.
Primary Outcome
The Modified Ashworth Scale (MAS) is 6-point scale designed to assess muscle tone and spasticity through the flexion or extension of a joint. Muscle response is graded on a scale from 0 (no increase in muscle tone) to 4 (affected parts rigid in flexion or extension). This includes a 1+ rating, which further distinguishes the types of increase in muscle tone from those described by a 1 or 2 rating.
Interventions
- DEVICE Treatment with Cryo-Touch III device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-10 |
| Phase | NA |
What the finished NCT01863901 record still lists
NCT01863901 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Treatment with Cryo-Touch III device is the first listed.
NCT01863901 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01863901 about?
NCT01863901 is a clinical study titled "Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device". A proof of concept study to evaluate the feasibility of safe and effective treatment of upper limb spasticity using the Cryo-Touch III Device.
What is the current status of trial NCT01863901?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2013-04. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01863901?
The interventions under investigation include: Treatment with Cryo-Touch III device (DEVICE).
Who is sponsoring clinical trial NCT01863901?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01863901's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia